D R Horton Slashes FY22 Outlook - Update

RTTNews | 670 hari yang lalu
D R Horton Slashes FY22 Outlook - Update

(RTTNews) - While reporting financial results for the third quarter on Thursday, home builder D R Horton Inc. (DHI) slashed its revenue and homes closed guidance for the full-year 2022, based on its results for the first nine months of fiscal 2022, expected completion dates of homes under construction and current market conditions.

For fiscal 2022, the company now projects consolidated revenues in a range of $33.8 billion to $34.6 billion on Homes closed between 83,000 homes and 85,000 homes.

Previously, the company expected consolidated revenues in a range of $35.3 billion to $36.1 billion on Homes closed between 88,000 homes and 90,000 homes.

On average, 16 analysts polled by Thomson Reuters expect the company to report revenues of $34.86 billion for the year.

Subsequent to quarter-end, the Company declared a quarterly cash dividend of $0.225 per common share that is payable on August 11, 2022 to stockholders of record on August 4, 2022.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

read more
D R Horton Boosts FY24 Outlook - Update

D R Horton Boosts FY24 Outlook - Update

While reporting financial results for the second quarter on Thursday, home builder D R Horton Inc. (DHI) raised its revenue and homes closed guidance for the full-year 2024, based on current market conditions and the Company's results for the first half of the year.
RTTNews | 33 hari yang lalu
European Shares Decline On US Rate Concerns

European Shares Decline On US Rate Concerns

European stocks edged lower on Tuesday following cautious comments from Federal Reserve officials on inflation and the interest rate outlook.
RTTNews | 5h 33menit yang lalu
Sanofi, OpenAI To Build AI Software To Boost Drug Development

Sanofi, OpenAI To Build AI Software To Boost Drug Development

French drug major Sanofi is teaming with artificial intelligence or AI startup OpenAI, the developer of highly popular generative AI chatbot ChatGPT, as well as Formation Bio, an AI and tech-driven drug developer, to build AI-powered software to accelerate drug development and bring new medicines more efficiently.
RTTNews | 5h 38menit yang lalu
DAX Dips On Rate Worries

DAX Dips On Rate Worries

German stocks traded lower on Tuesday after more Federal Reserve officials expressed caution on inflation, raising uncertainty over the pace of interest-rate cuts this year.
RTTNews | 6h 9menit yang lalu
Asian Shares Decline On Fed Rate Concerns

Asian Shares Decline On Fed Rate Concerns

Asian stocks ended lower on Tuesday as a stimulus-driven China rally paused and minutes of the May 2024 Reserve Bank of Australia meeting showed the central bank considered increasing interest rates during the meeting.
RTTNews | 6h 23menit yang lalu